Lv3
340 积分 2022-06-26 加入
Benign liver tumours: understanding molecular physiology to adapt clinical management
16天前
已完结
CLK1 Activates YAP to Promote Intrahepatic Cholangiocarcinogenesis
1个月前
已完结
CLK1 Activates YAP to Promote Intrahepatic Cholangiocarcinogenesis
2个月前
已完结
Adjuvant transarterial chemoembolization for hepatocellular carcinoma following curative resection: A randomized, open-label, phase 3 trial
3个月前
已关闭
Syngeneic Murine Models with Distinct Immune Microenvironments Represent Subsets of Human Intrahepatic Cholangiocarcinoma
1年前
已完结
ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosis
1年前
已完结
In vivo CRISPR screening identifies BAZ2 chromatin remodelers as druggable regulators of mammalian liver regeneration
2年前
已完结
Rheb regulates nuclear mTORC1 activity independent of farnesylation
2年前
已关闭
IFNα Potentiates Anti–PD-1 Efficacy by Remodeling Glucose Metabolism in the Hepatocellular Carcinoma Microenvironment
2年前
已完结
IFNα Potentiates Anti–PD-1 Efficacy by Remodeling Glucose Metabolism in the Hepatocellular Carcinoma Microenvironment
2年前
已完结
皖公网安备34019202002308
